N/A
N=94
Bone Health in Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral Muscular Dystrophy
Bottom Line
View on ClinicalTrials.gov: NCT02413190 ↗Enrolled (actual)
94
Serious AEs
0.0%
Results posted
Nov 2019
Primary outcome: Primary: Bone Mineral Density in FSHD — -0.4 z-score
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Primary completion
- Jul 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Bone Mineral Density in FSHD |
-0.4 | — |
Summary
This is a cross-sectional single visit study to determine bone health in individuals with FSHD.
Eligibility Criteria
Inclusion Criteria
- Genetic diagnosis of FSHD including chromosome 4 deletion and haplotype
- Age > 18 years
- Ability to provide written informed consent for participation in the study
- Ability to participate in the DEXA scan
Exclusion Criteria
- Unwillingness or inability to comply with the requirements of this protocol (in the opinion of the PI) including, but not limited to, the presence of any condition (physical, mental or social) that precludes the participant from comfortably and safely obtaining a DEXA scan, phlebotomy, or neurological examination
Data sourced from ClinicalTrials.gov (NCT02413190). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.